Sameeh M. Salama
Biochemistry
FEDORA Pharmaceuticals
Canada
Biography
Dr. Sameeh M. Salama is the vice president of business development at Fedora Pharmaceuticals Inc. He currently also holds the title of vice president of business development at Brass Dome Ventures Ltd., a management and business consultancy. Earlier in his career, Dr. Salama was vice president of the contract-research organization, NAEJA Pharmaceuticals Inc. In this role, he was actively involved in over a dozen licensing and partnership agreements, including the licensing of NAEJA’s Beta-lactamase inhibitors to Fedora Pharmaceuticals Inc. and later the licensing of the same assets to F. Hoffman La Roche in a record-setting US$750 million license deal.
Research Interest
Biochemistry
